Treatment of Pneumonia in a 3-Year-Old Child
Amoxicillin is the first-line treatment for community-acquired pneumonia in a 3-year-old child, administered at 90 mg/kg/day in 2 doses or 45 mg/kg/day in 3 doses for 5 days. 1, 2
Outpatient Management
First-line therapy:
- For mild to moderate community-acquired pneumonia (CAP) in previously healthy, fully immunized children:
Alternative therapy (for penicillin-allergic patients):
- Oral clindamycin 30-40 mg/kg/day divided in 3 doses 5, 2
- For suspected atypical pneumonia (Mycoplasma or Chlamydophila):
Inpatient Management
For hospitalized patients with non-severe pneumonia:
- Ampicillin 150-200 mg/kg/day divided every 6 hours 1, 2
- For areas with high prevalence of resistant pneumococci or incomplete immunization:
For suspected atypical pneumonia requiring hospitalization:
- Add a macrolide (e.g., azithromycin) to β-lactam therapy 1, 2
- Intravenous azithromycin 10 mg/kg on days 1 and 2 of therapy 1
Pathogen-Specific Considerations
Streptococcus pneumoniae:
- For penicillin-susceptible strains: amoxicillin as described above 1, 2
- For penicillin-resistant strains: higher dose amoxicillin (90 mg/kg/day) or alternative agents based on susceptibility 1, 2
Mycoplasma pneumoniae/Chlamydophila:
Staphylococcus aureus:
- For methicillin-susceptible S. aureus: cefazolin (150 mg/kg/day) or oxacillin (150-200 mg/kg/day) if hospitalized 1, 2
- For methicillin-resistant S. aureus: vancomycin or clindamycin based on susceptibility 1, 5
Haemophilus influenzae:
- Amoxicillin (75-100 mg/kg/day) for β-lactamase negative strains 1, 2
- Amoxicillin-clavulanate for β-lactamase producing strains 1, 2
Treatment Duration
- 5 days for uncomplicated CAP treated as outpatient 2, 3, 4
- Longer courses may be needed for complicated pneumonia or specific pathogens like S. aureus 2
Important Clinical Considerations
- Recent studies show that shorter antibiotic courses (5 days) are as effective as longer courses (10 days) for uncomplicated pneumonia, which helps reduce antibiotic resistance 3, 4
- Treatment failure is more likely in children younger than 12 months, those with symptoms lasting 3 days or longer before presentation, and those with higher respiratory rates 7
- Non-adherence to prescribed treatment is a significant risk factor for treatment failure 7
- Empiric therapy should be adjusted based on local resistance patterns and the child's vaccination status 2
- For children with uncomplicated lower respiratory tract infections where pneumonia is not clinically suspected, antibiotics may not provide significant benefit 8